Tonella, L.; Pala, V.; Ponti, R.; Rubatto, M.; Gallo, G.; Mastorino, L.; Avallone, G.; Merli, M.; Agostini, A.; Fava, P.;
et al. Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications. Int. J. Mol. Sci. 2021, 22, 4561.
https://doi.org/10.3390/ijms22094561
AMA Style
Tonella L, Pala V, Ponti R, Rubatto M, Gallo G, Mastorino L, Avallone G, Merli M, Agostini A, Fava P,
et al. Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications. International Journal of Molecular Sciences. 2021; 22(9):4561.
https://doi.org/10.3390/ijms22094561
Chicago/Turabian Style
Tonella, Luca, Valentina Pala, Renata Ponti, Marco Rubatto, Giuseppe Gallo, Luca Mastorino, Gianluca Avallone, Martina Merli, Andrea Agostini, Paolo Fava,
and et al. 2021. "Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications" International Journal of Molecular Sciences 22, no. 9: 4561.
https://doi.org/10.3390/ijms22094561
APA Style
Tonella, L., Pala, V., Ponti, R., Rubatto, M., Gallo, G., Mastorino, L., Avallone, G., Merli, M., Agostini, A., Fava, P., Bertero, L., Senetta, R., Osella-Abate, S., Ribero, S., Fierro, M. T., & Quaglino, P.
(2021). Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications. International Journal of Molecular Sciences, 22(9), 4561.
https://doi.org/10.3390/ijms22094561
